Gillman PK, 2010-02-08: Review arguing that 13 of the 14 then-reported cases of methylene blue CNS toxicity were serotonin toxicity meeting the Hunter criteria, caused by methylene blue's MAOI property interacting with serotonin reuptake inhibitors.
This review of the current evidence concludes that 13 of 14 of the reported cases of CNS toxicity were serotonin toxicity that met the Hunter Serotonin Toxicity Criteria.
Gillman PK, 2010-02-08: Review arguing that 13 of the 14 then-reported cases of methylene blue CNS toxicity were serotonin toxicity meeting the Hunter criteria, caused by methylene blue's MAOI property interacting with serotonin reuptake inhibitors. C1 case count, earlier than Zuschlag (14 cases in 2011 vs 50 by 2018). Study type: narrative review; N = 14 published cases. Country: Australia (PsychoTropical Research). Dose/route mentioned in abstract: intravenous, 1-7.5 mg/kg, for methemoglobinemia, vasoplegia and parathyroidectomy. Funder/conflicts: not stated in abstract. Comparator: none. This is the same author whose MAO-A work (Ramsay, Dunford, Gillman 2007) underpins the mechanism. Study type: review.
